Regulatory Challenges at the Intersection of Cellular and Medical Device Therapies in Europe: The Case of the Bioartificial Pancreas
Regenerative medicine solutions for type 1 diabetes are a rapidly developing field of medical technology. So far, these solutions have been principally cell-based treatments and, at present, in Europe, are regulated under the European Union regulations for Advanced Therapy Medicinal Products (ATMPs)...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Queensland University of Technology
2023-11-01
|
| Series: | Law, Technology and Humans |
| Assuntos: | |
| Acceso en liña: | https://lthj.qut.edu.au/article/view/3118 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|